Evaluation of one-stage and chromogenic assays for the laboratory measurement of factor VIII activity following valoctocogene roxaparvovec infusion

被引：1
|
作者：
Platton, Sean [1 ]
Raheja, Priyanka [1 ]
Dale, Christopher [2 ,3 ]
Guy, Susan [4 ]
Yartey, Nada [2 ,3 ]
Bowyer, Annette [4 ]
机构：
[1] Barts Hlth NHS Trust, Royal London Hosp, Haemophilia Ctr, London, England
[2] Barts Hlth NHS Trust, Royal London Hosp, Haemostasis Lab, London, England
[3] Barts Hlth NHS Trust, Natl Hlth Serv East & South East London Pathol Par, London, England
[4] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Dept Coagulat, London, England
来源：
HAEMOPHILIA | 2024年 / 30卷 / 05期
关键词：
GENE-THERAPY;
D O I：
10.1111/hae.15064
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1221 / 1224
页数：4
相关论文
共 50 条
  • [31] Activation profiles of factor VIII in concentrates reflect one-stage/chromogenic potency discrepancies
    Hubbard, AR
    Weller, LJ
    Bevan, SA
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (04) : 957 - 960
  • [32] Factor VIII:C measurement by different chromogenic and one stage assays in two Acquired Haemophilia patients treated with recombinant porcine factor VIII
    Guy, Susan
    Bowyer, Annette
    Kitchen, Steve
    HAEMOPHILIA, 2022, 28 : 47 - 48
  • [33] In vivo pharmacokinetics of recombinant factor VIII (recombinate) using one-stage clotting and chromogenic factor VIII assay.
    Lee, C
    Owens, D
    Lilley, P
    Giangrande, P
    Collins, P
    Hay, C
    Bray, G
    Gomperts, E
    Schroth, P
    Barrowscliffe, T
    BLOOD, 1997, 90 (10) : 143 - 143
  • [34] Prevalence of Discrepancy Between the Results of One-Stage and Chromogenic Factor VIII: C Assays in Iranian Patients with Mild / Moderate Hemophilia A
    Ahmadinejad, Minoo
    Vossough, Fatemeh
    Karimi, Kataioon
    Tabatabaei, Mohammad Reza
    Homayoun, Sanaz
    Karimi, Mehran
    Toogeh, Gholamreza
    BLOOD, 2016, 128 (22)
  • [35] A global comparative field study to evaluate the factor VIII activity of efanesoctocog alfa by one-stage clotting and chromogenic substrate assays at clinical haemostasis laboratories
    Pipe, Steven
    Sadeghi-Khomami, Ali
    Konkle, Barbara A.
    Kitchen, Steve
    Negrier, Claude
    Liu, Mingjie
    Santagostino, Elena
    Willemze, Annemieke
    Abad-Franch, Lydia
    Knobe, Karin
    Seth Chhabra, Ekta
    HAEMOPHILIA, 2024, 30 (01) : 214 - 223
  • [36] One-stage factor VIII assays are affected by both type and amount of phospholipids
    Mikaelsson, M
    Oswaldsson, U
    THROMBOSIS AND HAEMOSTASIS, 1999, : 574 - 574
  • [37] Novel mutations associated with a discrepancy between one-stage and chromogenic FVIII activity assays
    Provaznikova, D.
    Houskova, K.
    Radovska, A.
    Salaj, P.
    Hrachovinova, I.
    HAEMOPHILIA, 2015, 21 (04) : E330 - E332
  • [38] Inter-Laboratory Evaluation of the Recovery of Bay 94-9027 [Jivi®] with One-Stage Clotting and Chromogenic Assays
    Meijer, Piet
    Marlar, Richard A.
    Teare, John M.
    Adcock, Dorothy
    BLOOD, 2019, 134
  • [39] Prevalence, biological phenotype and genotype in moderate/mild hemophilia A with discrepancy between one-stage and chromogenic factor VIII activity
    Trossaert, M.
    Boisseau, P.
    Quemener, A.
    Sigaud, M.
    Fouassier, M.
    Ternisien, C.
    Lefrancois-Bettembourg, A.
    Tesson, C.
    Thomas, C.
    Bezieau, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (03) : 524 - 530
  • [40] Method validation and clinical utility of chromogenic factor VIII assay compared to one-stage assay
    Gouws, Wilmare
    Botha, Elsabie
    Visser, Adele
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2014, 37 (02) : 210 - 215
12345